174 results on '"Miyata-Takata, Tomoko"'
Search Results
2. EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome
3. Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population
4. Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma
5. Motive and opportunity: MYCrearrangements in high-grade B-cell lymphoma with MYCand BCL2rearrangements (an LLMPP study)
6. Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma.
7. Overexpression of folate receptor alpha is an independent prognostic factor for outcomes of pancreatic cancer patients
8. The spatially resolved tumor microenvironment predicts treatment outcome in relapsed/refractory Hodgkin lymphoma
9. Up-regulation of activation-induced cytidine deaminase and its strong expression in extra-germinal centres in IgG4-related disease
10. Supplementary Data from Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma
11. Data from Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma
12. Supplementary Data from Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands
13. Data from Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands
14. Myeloid sarcoma incidentally found in lymph nodes dissected for advanced gastric cancer
15. Spatial Tumor Microenvironment Characterization and Outcome of Relapsed/Refractory Classic Hodgkin Lymphoma
16. Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population
17. Low-grade B-cell lymphoma presenting primarily in the bone marrow
18. Gastrointestinal follicular lymphoma: Current knowledge and future challenges
19. Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands
20. Population-Wide Introduction of Dose-Adjusted EPOCH-R Is Associated with Improved Outcome of High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements with Diffuse Large B-Cell Lymphoma Morphology
21. Multi-Dimensional Molecular and Tumor-Microenvironment Analysis of Classic Hodgkin Lymphoma
22. A case of diffuse large B-cell lymphoma transformed from primary duodenal follicular lymphoma
23. Mutational landscape of gray zone lymphoma
24. Identification of LAG3+ T Cell Populations in the Tumor Microenvironment of Classical Hodgkin Lymphoma and B-Cell Non-Hodgkin Lymphoma
25. Single Cell Profiling Reveals Unique CXCL13 Positive T Cell Subsets in the Tumor Microenvironment of Lymphocyte Rich Classic Hodgkin Lymphoma
26. Impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC
27. Gene expression profiling of gray zone lymphoma
28. Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma
29. Mutational Landscape of Grey Zone Lymphoma
30. Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma
31. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
32. Identification of TRA‐1‐60‐positive cells as a potent refractory population in follicular lymphomas
33. Expression of T-cell receptor signalling pathway components in extranodal NK/T-cell lymphoma
34. Reappraisal of nodal Epstein‐Barr Virus‐negative cytotoxic T‐cell lymphoma: Identification of indolent CD 5 + diseases
35. Characteristic Distribution Pattern of CD30-positive Cytotoxic T Cells Aids Diagnosis of Kikuchi-Fujimoto Disease
36. The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC
37. The impact of MYCand BCL2structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC
38. Primary cutaneous NK/T-cell lymphoma of nasal type: an age-related lymphoproliferative disease?
39. Clinicopathological analysis of primary central nervous system NK/T cell lymphoma: rare and localized aggressive tumour among extranasal NK/T cell tumours
40. Frequent downregulation of BTB and CNC homology 2 expression in Epstein-Barr virus-positive diffuse large B-cell lymphoma
41. Clinicopathological analysis of 12 patients with Epstein-Barr virus-positive primary intestinal T/natural killer-cell lymphoma (EBV+ ITNKL)
42. Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway
43. Identification of TRA-1-60-Positive Cells As a Potent Refractory Population in Follicular Lymphomas
44. Identification of TRA‐1‐60‐positive cells as a potent refractory population in follicular lymphomas.
45. EBV+nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome
46. CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine
47. Protocadherin γ A3 is expressed in follicular lymphoma irrespective of BCL2 status and is associated with tumor cell growth
48. Clinicopathological features of 49 primary gastrointestinal diffuse large B-cell lymphoma cases; comparison with location, cell-of-origin, and frequency of MYD88 L265P
49. Comparison of prognoses according to non‐positive and positive spectrin α II expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.
50. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.